Compounds and liquid-crystalline medium

US2018216005A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2018216005-A1
Application numberUS-201815883976-A
CountryUS
Kind codeA1
Filing dateJan 30, 2018
Priority dateJan 30, 2017
Publication dateAug 2, 2018
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Compounds of the formula I, and liquid-crystalline media, preferably having a nematic phase and negative dielectric anisotropy, comprising a) one or more compounds of the formula I and one or more compounds selected from b) one or more compounds of formula II and/or c) one or more compounds selected from compounds of formulae III-1 to III-4 and formula B Methods for making and using these liquid-crystalline media in electro-optical displays, particularly in active-matrix displays based on the VA, ECB, PALC, FFS or IPS effect and the displays which contain these media. Methods for stabilizing liquid-crystalline media with compounds of formula I, where the liquid-crystalline media comprise one or more compounds of the formula II and one or more compounds selected from compounds of the formulae III-1 to III-4 and formula B.

First claim

Opening claim text (preview).

1 . A liquid crystalline medium comprising a) one or more compounds of the formula I, in which R 11 on each occurrence, independently of one another, denotes H, F, a straight-chain or branched alkyl chain having 1-20 C atoms, in which one —CH 2 -group or, if present, a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, and one or, if present, a plurality of —CH 2 -groups may be replaced by—CH═CH— or —C≡C—, and in which one H atom or a plurality of H atoms may be replaced by F, OR 13 , N( R 13 )(R 14 ) or R 15 , R 12 on each occurrence, independently of one another, denotes H, a straight-chain or branched alkyl chain having 1-20 C atoms, in which one —CH 2 -group or a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, a hydrocarbon radical which contains a cycloalkyl or alkylcycloalkyl unit and in which one —CH 2 -group or a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, and in which one H atom or a plurality of H atoms may be replaced by OR 13 , N(R 13 )(R 14 ) or R 15 , or an aromatic or heteroaromatic hydrocarbon radical, in which one H atom or a plurality of H atoms may be replaced by F, OR 13 , N(R 13 )(R 14 ) or R 15 , R 13 on each occurrence, independently of one another, denotes H, a straight-chain or branched alkyl or acyl group having 1 to 10 C atoms or an aromatic hydrocarbon or carboxylic acid radical having 6-12 C atoms, R 14 on each occurrence, independently of one another, denotes H, a straight-chain or branched alkyl or acyl group having 1 to 10 C atoms or an aromatic hydrocarbon or carboxylic acid radical having 6 to 12 C atoms, R 15 on each occurrence, independently of one another, denotes a straight-chain or branched alkyl group having 1 to 10 C atoms, in which one —CH 2 -group or a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, S 11 and S 12 on each occurrence, independently of one another, denote an alkylene group having 1 to 20 C atoms, which can be branched or straight-chain, in which one —CH 2 -group or, if present, a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, and one or, if present, a plurality of —CH 2 -groups may be replaced by —CH═CH— or —C≡C— and in which one H atom or a plurality of H atoms may be replaced by F, OR 13 , N(R 13 )(R 14 ) or R 15 , or denote a single bond, Y 11 to Y 14 each, independently of one another, denote methyl or ethyl, Z 11 to Z 14 on each occurrence, independently of one another, denote —O—, —(C═O)—, —O—(C═O)—, —(C═O)—O—, —O—(C═O)—O—, —(N—R 13 )—,or —N—R 13 —(C═O)— or additionally a single bond if S 11 is a single bond, provided that both Z 11 and Z 12 do not simultaneously denote —O—, and, provided that, if S 12 is a single bond, both Z 13 and Z 14 do not simultaneously denote —O—, and, provided that , if —X 11 [—R 11 ] 0 — is a single bond, both Z 12 and Z 13 do not simultaneously denote —O—, P denotes 1 o 2, o denotes (3-p), n * p denotes an integer from 3 to 10, in the case where p=1, n denotes an integer from 3 to 10, m denotes (10-n), and in the case where p=2, n denotes an integer from 2 to 4, and m denotes (4-n), denotes an organic radical having (m+n) bonding sites, X 11 denotes C, and in the case where p=1, —X 11 [—R 11 ] 0 — may alternatively also denote a single bond, and one or more further compounds selected from: b) one or more compounds of the formula II in which R 21 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkenyl radical having 2 to 7 C atoms, and R 22 denotes an unsubstituted alkenyl radical having 2 to 7 C atoms, and/or c) one or more compounds selected from the group of the compounds of the formulae III-1 to III-4 and B, in which R 31 denotes an unsubstituted alkyl radical having 1 to 7 C atoms, R 32 denotes an unsubstituted alkyl radical having 1 to 7 C atoms or an unsubstituted alkoxy radical having 1 to 6 C atoms, m, n and o each, independently of one another, denote 0 or 1, R B1 and R B2 each, independently of one another, denote an unsubstituted alkyl radical, alkoxy radical, oxaalkyl radical or alkoxyalkyl radical having 1 to 7 C atoms, or an alkenyl radical or alkenyloxy radical having 2 to 7 C atoms, and L B1 and L B2 each, independently of one another, denote F or Cl. 2 . A medium according to claim 1 , wherein the total concentration of the compounds of the formula I in the medium as a whole is from 1 ppm to 2500 ppm. 3 . A medium according to claim 1 , which comprises a compound of the formula II in which R 21 denotes n-propyl and R 22 denotes vinyl. 4 . A medium according to claim 3 , wherein the total concentration of the compounds of the formula II in the medium as a whole is from 25% to 45%. 5 . A medium according to claim 1 , which comprises one or more compounds of the formula B. 6 . A medium according to claim 1 , which comprises one or more compounds of the formula III-4. 7 . A medium according to claim 1 , which additionally comprises one or more chiral compounds. 8 . A compound of the formula I in which R 11 on each occurrence, independently of one another, denotes H, F, a straight-chain or branched alkyl chain having 1-20 C atoms, in which one —CH 2 -group or, if present, a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, and one or, if present, a plurality of —CH 2 -groups may be replaced by—CH═CH— or —C≡C—, and in which one H atom or a plurality of H atoms may be replaced by F, OR 13 , N(R 3 )(R 14 ) or R 15 , R 12 on each occurrence, independently of one another, denotes H, a straight-chain or branched alkyl chain having 1-20 C atoms, in which one —CH 2 -group or a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, a hydrocarbon radical which contains a cycloalkyl or alkylcycloalkyl unit and in which one —CH 2 -group or a plurality of —CH 2 -groups may be replaced by —O— or —C(═O)—, but two adjacent —CH 2 -groups cannot be replaced by —O—, and in which one H atom or a plurality of H atoms may be replaced by OR 13 , N(R 13 )(R 14 ) or R 15 , or an aromatic or heteroaromatic hydrocarbon radical, in which one H atom or a plurality of H atoms may be replaced by F, OR 13 , N(R 13 )(R 14 ) or R 15 , R 13 on each occurrence, independently of one another, denotes H, a straight-chain or branched alkyl or acyl group having 1 to 10 C atoms or an aromatic hydrocarbon or carboxylic acid radical having 6-12 C atoms, R 14 on each occurrence, independently of one another, denotes H, a straight-chain or branched alkyl or acyl group having 1 to 10 C atoms or an aromatic hydroca

Assignees

Inventors

Classifications

  • Compounds containing at least two rings in which the different rings are directly linked (covalent bond) · CPC title

  • C09K19/44Primary

    containing compounds with benzene rings directly linked · CPC title

  • Cy-Ph-Ph · CPC title

  • Ph-Ph-Ph · CPC title

  • the heterocyclic ring being a six-membered aromatic ring containing one nitrogen atom, e.g. pyridine · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2018216005A1 cover?
Compounds of the formula I, and liquid-crystalline media, preferably having a nematic phase and negative dielectric anisotropy, comprising a) one or more compounds of the formula I and one or more compounds selected from b) one or more compo…
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/44. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Aug 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 2 related publications on this page (citations in our corpus or others sharing the same primary CPC).